Page last updated: 2024-08-24

atorvastatin and Recrudescence

atorvastatin has been researched along with Recrudescence in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (2.82)	18.2507
2000's	32 (45.07)	29.6817
2010's	32 (45.07)	24.3611
2020's	5 (7.04)	2.80

Authors

Authors	Studies
Guan, JW; Sun, T; Wu, K; You, C; Yuan, YK	1
Li, Q; Liu, S; Tang, X; Xu, W; Yang, F	1
Civeira, F; Fuentes, F; Laclaustra, M; Marco-Benedi, V; Ortega, E; Perez-Calahorra, S; Pinto, X; Plana, N; Sanchez-Hernandez, RM	1
Dong, J; Gao, C; Huang, J; Jiang, R; Zhang, J	1
Alonso-Canovas, A; Chico-García, JL; Cruz-Culebras, A; de Felipe Mimbrera, A; García-Madrona, S; Gómez-López, A; Masjuan, J; Matute-Lozano, C; Natera-Villalba, E; Ros-Castelló, V; Sánchez-Sánchez, A; Vera-Lechuga, R	1
Chen, P; He, S; Wang, C; Wang, D; Wang, H; Wen, J; Xu, M; Yu, B; Zeng, W; Zhang, H	1
Andrés Marín, N; Antigüedad-Muñoz, J; Arenaza Choperena, G; de la Riva, P; Fernández-Eulate, G; Martínez Zabaleta, M; Moreno Valladares, M; Muñoz Lopetegi, A	1
Chen, Y; Feng, H; Gao, B; Li, X; Shi, J; Tang, R; Wang, L; Yan, R; Zou, Y	1
Brown, TM; Carson, AP; Colantonio, LD; Dai, Y; Farkouh, ME; Giustino, G; Monda, KL; Muntner, P; Rosenson, RS	1
Cheng, X; Liu, Q; Wang, Y	1
Dong, J; Gao, C; Huang, J; Jiang, R; Li, L; Quan, W; Sun, J; Tian, Q; Tian, Y; Wang, D; Zhang, J	1
Brodowski, K; Jaworski, K; Kosior, DA; Krzykwa, A; Opolski, G; Zylińska, E	1
Albers, GW; Tai, WA	1
Li, Y; Qi, X; Yang, Q	1
Cozzi, R; Lo Schiavo, A; Puca, RV; Romano, F	1
Ebisawa, S; Ikeda, U; Izawa, A; Kagoshima, M; Kashima, Y; Kitabayashi, H; Koyama, J; Miura, T; Miyashita, Y; Sakurai, S; Tomita, T; Yamamoto, H	1
Dubrovins'ka, TV; Skrypnyk, IM	1
Abdel-Rahman, I; Murphy, C	1
Carreño-Rojo, A; Chica-Marchal, A; Huertas, AJ; Mérida-Fernández, C; Ramírez-Hernández, M	1
Cannon, CP; Khera, AV; Murphy, SA; Qamar, A; Rader, DJ; Sabatine, MS	1
Chauvet, C; Jaber, M; Lafay-Chebassier, C; Nicolas, C; Solinas, M; Thiriet, N	1
Dang, Y; Hao, X; Qi, X; Song, X; Yang, Q	1
Dong, J; Liao, L; Liu, F; Liu, J; Mou, Y; Shen, X; Yang, T; Zhou, X	1
Bao, W; Byun, YS; DeMicco, D; Laskey, R; Tsimikas, S; Witztum, JL; Yang, X	1
Dolci, GS; Medeiros Fossati, AC; Onofre de Souza, D; Portela, LV	1
Elsais, A; Kerty, E; Lund, C	1
Császár, A	1
Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Sillesen, H; Welch, KM; Zivin, J	1
Hanhart, J; Koskas, P; Le Mer, Y; Obadia, M; Paques, M; Sahel, JA	1
Braunwald, E; Cairns, R; Cannon, CP; Morrow, DA; Ray, KK; Ridker, PM	1
Alt, M; Andrès, E	1
Bao, W; Ganz, P; Kinlay, S; Libby, P; Olsson, AG; Rifai, N; Schwartz, GG	1
Cho, DK; Cho, JR; Cho, YH; Choi, D; Hong, MK; Jang, Y; Jeon, DW; Kim, BK; Kim, J; Kim, JS; Ko, YG; Lee, CJ; Lee, NH; Lee, SH; Oh, SJ; Yang, JY	1
Colivicchi, F; Genovesi Ebert, A; Melina, G; Mocini, D; Santini, M; Strano, S; Tubaro, M; Uguccioni, M	1
Dougu, N; Nukui, T; Taguchi, Y; Takashima, S; Tanaka, K; Toyoda, S	1
Dermitzakis, I; Drakoulis, C; Gialernios, K; Gialernios, T; Gika, E; Iliopoulos, N; Katsadorou, E; Kougialis, S; Kroustalis, A; Mpilinis, H; Nikolaou, S; Polydorou, A; Polydorou, V; Skopelitis, E; Zervou, A	1
Cannon, CP; Khera, AV; Qin, J; Rader, DJ; Wolfe, ML	1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, S; Rosenqvist, M; Tornvall, P	1
Djoussé, L; Gaziano, JM; Rahilly-Tierney, C; Sesso, HD	1
Sillence, D; Tchan, M	1
Chedgy, F; Howlett, DC; Inglis, C	1
Cannon, CP; De Lemos, JA; Morrow, DA; Ray, KK; Rifai, N; Sabatine, MS; Wilson, SR; Wiviott, SD; Zhou, S	1
Almroth, H; Andersson, J; Boman, K; Englund, A; Höglund, N; Jensen, SM; Rosenqvist, M; Tornvall, P	1
Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL	1
Ammirati, F; Colivicchi, F; Guido, V; Montefoschi, N; Santini, M; Tubaro, M; Varveri, A	1
Aktas, O; Brocke, S; Dorr, J; Endres, M; Nitsch, R; Prozorovski, T; Sallach, S; Seeger, B; Smorodchenko, A; Waiczies, S; Zipp, F	1
Baumgartner, RW; Georgiadis, D	1
Correia, LC; D'Oliveira, A; Esteves, JP; Magalhães, LP; Passos, LC; Rocha, MS; Santana, O; Spósito, AC	1
Ganz, P; Kinlay, S; Libby, P; Olsson, AG; Rifai, N; Sasiela, WJ; Schwartz, GG; Szarek, M	1
Dolan, JG; Nautiyal, A; Singh, S	1
Casciano, R; Gómez-Gerique, JA; Rejas, J; Stern, L	1
Ezekowitz, MD; Ganz, P; Oliver, MF; Olsson, AG; Sasiela, WJ; Schwartz, GG; Szarek, M; Waters, D; Zeiher, A	1
Lavoie, S; Lipson, J; Zimmerman, D	1
Olsson, AG; Sasiela, WJ; Schwartz, GG; Szarek, M	1
Clearfield, M	1
Altinbas, A; Aslan, SM; Dogan, A; Kucuktepe, Z; Ozaydin, M; Ozturk, M; Varol, E	1
Cía, M; Martínez, M; Otermin, I; Pereda, A; Rivero, M	1
Choudhry, NK; Levin, R; Winkelmayer, WC	1
Heering, NJ	1
Antel, J; Arnold, DL; Bar-Or, A; Bodner, CA; Campagnolo, D; Garren, H; Gianettoni, J; Jalili, F; Kachuck, N; Lapierre, Y; Niino, M; Oger, J; Price, M; Rhodes, S; Robinson, WH; Shi, FD; Steinman, L; Utz, PJ; Valone, F; Vollmer, T; Weiner, L	1
Braunwald, E; Cannon, CP; Miller, M; Murphy, SA; Qin, J; Ray, KK	1
Karam, JG; Loney-Hutchinson, L; McFarlane, SI	1
Aktas, O; Bellmann-Strobl, J; Dörr, J; Haertle, M; Paul, F; Volk, HD; Waiczies, H; Waiczies, S; Wernecke, KD; Wuerfel, J; Zipp, F	1
Ballantyne, CM; Davidson, MH; Hanefeld, M; Johnson, JL; Mohler, ER; Ruilope, LM; Zalewski, A	1
Black, D; Chaitman, BR; Ezekowitz, MD; Ganz, P; Kane, JP; Oliver, MF; Olsson, AG; Pressler, ML; Schwartz, GG; Texter, M; Waters, D	1
Baim, DS; Carrozza, JP; Cohen, DJ	1
Auch-Schwelk, W; Elsner, M; Mach, S; Schächinger, V; Walter, DH; Zeiher, AM	1
Dotani, MI; Elnicki, DM; Gibson, CM; Jain, AC	1
Chaitman, BR; Ezekowitz, MD; Ganz, P; Leslie, S; Oliver, MF; Olsson, AG; Schwartz, GG; Stern, T; Waters, D; Zeiher, A	1

Reviews

5 review(s) available for atorvastatin and Recrudescence

Article	Year
Drug treatment of chronic subdural hematoma. Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:4 Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Atorvastatin; Diuretics; Hematoma, Subdural, Chronic; Humans; Incidence; Recurrence; Treatment Outcome	2020
The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials. BMC cardiovascular disorders, 2014, Aug-13, Volume: 14 Topics: Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Chi-Square Distribution; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Odds Ratio; Primary Prevention; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Secondary Prevention; Treatment Outcome	2014
[Impact of statin therapy on recurrence of persistent atrial fibrillation after electrical cardioversion: a meta-analysis]. Zhonghua xin xue guan bing za zhi, 2015, Volume: 43, Issue:11 Topics: Atorvastatin; Atrial Fibrillation; Electric Countershock; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized Controlled Trials as Topic; Recurrence	2015
[Important aim of statin therapy: ischemic cardiovascular event (stroke)]. Ideggyogyaszati szemle, 2008, Jul-30, Volume: 61, Issue:7-8 Topics: Acute Disease; Atorvastatin; Brain Ischemia; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Meta-Analysis as Topic; Myocardial Ischemia; Pyrroles; Recurrence; Stroke	2008
[Secondary prevention after ischemic stroke]. Praxis, 2003, Jan-29, Volume: 92, Issue:5 Topics: Administration, Oral; Angioplasty, Balloon; Anticholesteremic Agents; Anticoagulants; Aspirin; Atorvastatin; Carotid Stenosis; Endarterectomy, Carotid; Female; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Placebos; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Smoking Prevention; Stents; Stroke; Vertebral Artery Dissection	2003

Trials

22 trial(s) available for atorvastatin and Recrudescence

Article	Year
Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction – ALPS-AMI study. Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:1 Topics: Aged; Atorvastatin; Cardiovascular Diseases; Cholesterol; Cholesterol, LDL; Female; Glycated Hemoglobin; Heart Failure; Hospitalization; Humans; Hydrophobic and Hydrophilic Interactions; Hypercholesterolemia; Japan; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Patient Acceptance of Health Care; Pravastatin; Recurrence; Single-Blind Method; Solubility	2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study). The American journal of cardiology, 2015, Sep-01, Volume: 116, Issue:5 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Leptin; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pravastatin; Pyrroles; Recurrence; Resistin; Retrospective Studies; Risk Factors; Survival Rate; Thrombolytic Therapy; United States	2015
Oxidized Phospholipids on Apolipoprotein B-100 and Recurrent Ischemic Events Following Stroke or Transient Ischemic Attack. Journal of the American College of Cardiology, 2017, Jan-17, Volume: 69, Issue:2 Topics: Aged; Apolipoprotein B-100; Atorvastatin; Biomarkers; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Phospholipids; Proportional Hazards Models; Recurrence; Secondary Prevention; Stroke	2017
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:3 Topics: Acute Coronary Syndrome; Apolipoprotein A-I; Apolipoproteins B; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Proportional Hazards Models; Pyrroles; Recurrence; Risk Assessment; Time Factors; Treatment Outcome	2009
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. Atherosclerosis, 2009, Volume: 206, Issue:2 Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Female; Fibrin Fibrinogen Degradation Products; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Recurrence; Risk; Tissue Plasminogen Activator	2009
Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC. Cardiovascular interventions, 2010, Volume: 3, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Circulation; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Korea; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Pyrroles; Recurrence; Ticlopidine; Time Factors; Treatment Outcome	2010
Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease. Current medical research and opinion, 2010, Volume: 26, Issue:6 Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Coronary Artery Disease; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Italy; Male; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Recurrence; Treatment Outcome	2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study). The American journal of cardiology, 2010, Aug-15, Volume: 106, Issue:4 Topics: Acute Coronary Syndrome; Atorvastatin; C-Reactive Protein; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Risk Factors; Triglycerides	2010
Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion. Thrombosis research, 2011, Volume: 127, Issue:3 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Electric Countershock; Female; Fibrinolysis; Heptanoic Acids; Humans; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pyrroles; Recurrence; Tissue Plasminogen Activator	2011
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PR American heart journal, 2011, Volume: 161, Issue:6 Topics: Acute Coronary Syndrome; Adiponectin; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Female; Heart Failure; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Recurrence; Risk Assessment	2011
The predictive value of C-reactive protein on recurrence of atrial fibrillation after cardioversion with or without treatment with atorvastatin. International journal of cardiology, 2013, Sep-01, Volume: 167, Issue:5 Topics: Aged; Atorvastatin; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Double-Blind Method; Electric Countershock; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrroles; Recurrence; Treatment Outcome	2013
Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. The American journal of cardiology, 2002, Oct-15, Volume: 90, Issue:8 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Pyrroles; Recurrence; Survival Rate	2002
Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or non-ST-elevation acute myocardial infarction. The American journal of cardiology, 2003, Jun-01, Volume: 91, Issue:11 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Recurrence; Treatment Outcome	2003
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation, 2004, Jul-27, Volume: 110, Issue:4 Topics: Aged; Angina Pectoris; Angina, Unstable; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Biomarkers; CD40 Ligand; Double-Blind Method; Female; Heart Arrest; Heptanoic Acids; Humans; Inflammation Mediators; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Pyrroles; Recurrence; Risk; Solubility; Treatment Outcome	2004
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. European heart journal, 2005, Volume: 26, Issue:9 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Lipoproteins, HDL; Male; Myocardial Infarction; Myocardial Ischemia; Prognosis; Proportional Hazards Models; Pyrroles; Recurrence	2005
Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. Diabetes care, 2005, Volume: 28, Issue:10 Topics: Acute Disease; Aged; Atorvastatin; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Metabolic Syndrome; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Pyrroles; Recurrence; Risk Factors; Treatment Outcome	2005
Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. The American journal of cardiology, 2006, May-15, Volume: 97, Issue:10 Topics: Aged; Anti-Arrhythmia Agents; Atorvastatin; Atrial Fibrillation; Body Mass Index; C-Reactive Protein; Electric Countershock; Female; Heptanoic Acids; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Factors; Treatment Outcome	2006
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Archives of neurology, 2007, Volume: 64, Issue:10 Topics: Adult; Atorvastatin; Disability Evaluation; Double-Blind Method; Endpoint Determination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunization; Injections, Intramuscular; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Oligonucleotide Array Sequence Analysis; Plasmids; Pyrroles; Recurrence; T-Lymphocytes; Vaccines, DNA	2007
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2008, Feb-19, Volume: 51, Issue:7 Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Risk Assessment; Triglycerides	2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PloS one, 2008, Apr-09, Volume: 3, Issue:4 Topics: Adjuvants, Immunologic; Administration, Oral; Atorvastatin; Gadolinium; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-beta; Interleukins; Magnetic Resonance Imaging; Models, Biological; Multiple Sclerosis, Relapsing-Remitting; Multivariate Analysis; Pyrroles; Recurrence; Treatment Outcome	2008
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-bl Journal of the American College of Cardiology, 2008, Apr-29, Volume: 51, Issue:17 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Anti-Inflammatory Agents; Anticholesteremic Agents; Atorvastatin; Benzaldehydes; Biomarkers; Coronary Artery Disease; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukins; Male; Middle Aged; Oximes; Prognosis; Pyrroles; Recurrence; Risk Factors	2008
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA, 2001, Apr-04, Volume: 285, Issue:13 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Pyrroles; Recurrence; Survival Analysis	2001

Other Studies

44 other study(ies) available for atorvastatin and Recrudescence

Article	Year
Effects of postoperative atorvastatin use in elderly patients with chronic subdural hematoma. European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:23 Topics: Aged; Aged, 80 and over; Atorvastatin; Female; Hematoma, Subdural, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Postoperative Period; Recurrence; Retrospective Studies; Treatment Outcome	2021
Efficacy of atorvastatin administration after surgery in patients with chronic subdural hematoma. Medicine, 2023, Sep-29, Volume: 102, Issue:39 Topics: Activities of Daily Living; Atorvastatin; Hematoma; Hematoma, Subdural, Chronic; Humans; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Treatment Outcome	2023
Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence. Lipids in health and disease, 2019, Dec-11, Volume: 18, Issue:1 Topics: Aged; Atherosclerosis; Atorvastatin; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Recurrence; Registries; Retrospective Studies; Rosuvastatin Calcium; Secondary Prevention; Spain; Therapeutic Equivalency	2019
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients. Cerebrovascular diseases extra, 2020, Volume: 10, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atorvastatin; Cerebrovascular Disorders; Drug Combinations; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Medication Adherence; Middle Aged; Platelet Aggregation Inhibitors; Ramipril; Recurrence; Retrospective Studies; Secondary Prevention; Tablets; Tertiary Care Centers; Time Factors; Treatment Outcome	2020
The effect of atorvastatin on recurrence of chronic subdural hematoma after novel YL-1 puncture needle surgery. Clinical neurology and neurosurgery, 2021, Volume: 202 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atorvastatin; Combined Modality Therapy; Drainage; Female; Hematoma, Subdural, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neurosurgical Procedures; Postoperative Care; Punctures; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult	2021
Internal Carotid Artery Web as the Cause of Recurrent Cryptogenic Ischemic Stroke. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:5 Topics: Adult; Aspirin; Atorvastatin; Biopsy; Brain Ischemia; Cardiovascular Agents; Carotid Artery Diseases; Carotid Artery, Internal; Computed Tomography Angiography; Female; Fibromuscular Dysplasia; Humans; Hyperplasia; Neointima; Recurrence; Risk Factors; Stroke	2018
Effects of Atorvastatin on Surgical Treatments of Chronic Subdural Hematoma. World neurosurgery, 2018, Volume: 117 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atorvastatin; Combined Modality Therapy; Craniotomy; Diabetes Complications; Drug Administration Schedule; Female; Hematoma, Subdural, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Preoperative Care; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult	2018
Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus. Cardiovascular drugs and therapy, 2018, Volume: 32, Issue:5 Topics: Administrative Claims, Healthcare; Aged; Atorvastatin; Biomarkers; Databases, Factual; Diabetes Mellitus; Drug Prescriptions; Dyslipidemias; Female; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Medicare Part D; Myocardial Infarction; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Secondary Prevention; Time Factors; Treatment Outcome; United States	2018
The functional effect of atorvastatin dose-dependent via inflammation factors on acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention. Journal of cardiovascular medicine (Hagerstown, Md.), 2019, Volume: 20, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Dose-Response Relationship, Drug; Emergencies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Male; Middle Aged; Percutaneous Coronary Intervention; Quality of Life; Recurrence; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome	2019
Treatment of Relapsed Chronic Subdural Hematoma in Four Young Children with Atorvastatin and Low-dose Dexamethasone. Pharmacotherapy, 2019, Volume: 39, Issue:7 Topics: Atorvastatin; Child; Child, Preschool; Dexamethasone; Dose-Response Relationship, Drug; Drainage; Drug Administration Schedule; Drug Therapy, Combination; Hematoma, Subdural, Chronic; Humans; Infant; Male; Recurrence; Treatment Outcome	2019
[Role of inflammation in etiology of atrial fibrillation--is lone arrhythmia really alone]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:4 Topics: Atorvastatin; Atrial Fibrillation; C-Reactive Protein; Fibrinogen; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Pyrroles; Recurrence	2012
Secondary prevention of atherothrombotic or cryptogenic stroke. Circulation, 2014, Jan-28, Volume: 129, Issue:4 Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Clopidogrel; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Life Style; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Risk Factors; Secondary Prevention; Stroke; Ticlopidine	2014
Pemphigus erythematosus relapse associated with atorvastatin intake. Drug design, development and therapy, 2014, Volume: 8 Topics: Atorvastatin; Heptanoic Acids; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Pemphigus; Pyrroles; Recurrence	2014
[Negative effects of termination statinotherapy in patients after acute coronary event with concominent non-alcoholic steatohepatitis]. Likars'ka sprava, 2014, Issue:11 Topics: Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Drug Administration Schedule; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Non-alcoholic Fatty Liver Disease; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides; Triglycerides	2014
Recurrent ischaemic stroke unveils polycythaemia vera. BMJ case reports, 2015, Mar-09, Volume: 2015 Topics: Aspirin; Atorvastatin; Bloodletting; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Polycythemia Vera; Pyrroles; Recurrence; Stroke; Treatment Outcome	2015
Fixed drug eruption due to atorvastatin. Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:2 Topics: Aged, 80 and over; Atorvastatin; Drug Eruptions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Patch Tests; Predictive Value of Tests; Pyrroles; Recurrence; Risk Factors	2015
Statins Reduce the Risks of Relapse to Addiction in Rats. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:6 Topics: Animals; Atorvastatin; Brain; Cocaine-Related Disorders; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Rats; Rats, Sprague-Dawley; Recurrence; Risk Factors; Simvastatin; Substance-Related Disorders	2016
The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model. BMC cardiovascular disorders, 2016, 07-16, Volume: 16 Topics: Angioplasty, Balloon; Animals; Atherosclerosis; Atorvastatin; Cell Movement; Cell Proliferation; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Iliac Artery; Male; Myocytes, Smooth Muscle; Neointima; Rabbits; Recurrence; Time Factors; Vascular Patency; Vascular System Injuries	2016
Atorvastatin-induced osteoclast inhibition reduces orthodontic relapse. American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics, 2017, Volume: 151, Issue:3 Topics: Animals; Atorvastatin; Bone Remodeling; Femur; Immunohistochemistry; Male; Maxilla; Osteoclasts; Osteoprotegerin; RANK Ligand; Rats; Rats, Wistar; Recurrence; Tooth Mobility; Tooth Movement Techniques	2017
Ptosis, diplopia and statins: an association? European journal of neurology, 2008, Volume: 15, Issue:10 Topics: Adult; Atorvastatin; Autoantibodies; Autoimmune Diseases of the Nervous System; Azetidines; Blepharoptosis; Diabetes Complications; Diagnostic Errors; Diplopia; Eyelid Diseases; Ezetimibe; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Myasthenia Gravis; Myocardial Infarction; Pain; Pravastatin; Pyrroles; Receptors, Cholinergic; Recurrence; Strabismus	2008
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke, 2008, Volume: 39, Issue:12 Topics: Aged; Atorvastatin; Brain Ischemia; Carotid Stenosis; Cerebral Hemorrhage; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Treatment Outcome	2008
[Brain hypoperfusion revealed by an ocular ischemic syndrome]. Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:8 Topics: Antihypertensive Agents; Aspirin; Atorvastatin; Brain Ischemia; Carotid Artery Thrombosis; Ciliary Body; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Ischemia; Light Coagulation; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Middle Aged; Ophthalmic Artery; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Stroke; Ultrasonography	2008
[Pubalgia in athlete treated by atorvastatin]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:4 Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Atorvastatin; Drug Therapy, Combination; France; Heptanoic Acids; Humans; Male; Muscular Diseases; Pelvic Pain; Prednisone; Pyrroles; Recurrence; Sports	2009
[Case of branch atheromatous disease presenting capsular warning syndrome]. Rinsho shinkeigaku = Clinical neurology, 2010, Volume: 50, Issue:5 Topics: Anticoagulants; Aspirin; Atherosclerosis; Atorvastatin; Dextrans; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Heptanoic Acids; Humans; Infusions, Intravenous; Ischemic Attack, Transient; Magnetic Resonance Angiography; Male; Middle Aged; Pyrroles; Recurrence; Syndrome; Thrombolytic Therapy; Tissue Plasminogen Activator	2010
Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:4 Topics: Aged; Aged, 80 and over; Angioplasty; Atorvastatin; Biomarkers; Carotid Stenosis; Cross-Sectional Studies; Down-Regulation; Female; Greece; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Lipoproteins, LDL; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pyrroles; Recurrence; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed	2010
Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians. American heart journal, 2011, Volume: 161, Issue:4 Topics: Aged; Atorvastatin; Cholesterol, HDL; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Risk Reduction Behavior; Stroke; Time Factors; Treatment Outcome	2011
Fabry disease and Factor V Leiden: a potent vascular risk combination. Internal medicine journal, 2011, Volume: 41, Issue:5 Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defibrillators, Implantable; Drug Therapy, Combination; Enzyme Replacement Therapy; Fabry Disease; Factor V; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metoprolol; Middle Aged; Perindopril; Pyrroles; Quality of Life; Recurrence; Sequence Deletion; Stents; Stroke; Stroke Rehabilitation; Thrombophilia; Warfarin	2011
A case of recurrent ventricular tachycardia. BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342 Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin	2011
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry). Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Sep-01, Volume: 82, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome	2013
[Stable angina pectoris. PTCA improves symptoms, but not prognosis]. MMW Fortschritte der Medizin, 2002, Sep-26, Volume: 144, Issue:39 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atorvastatin; Combined Modality Therapy; Heptanoic Acids; Humans; Hypercholesterolemia; Prognosis; Pyrroles; Recurrence; Risk Factors; Stents; Treatment Outcome	2002
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. The Journal of experimental medicine, 2003, Mar-17, Volume: 197, Issue:6 Topics: Animals; Apoptosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; Genes, MHC Class II; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Paralysis; Peptide Fragments; Pyrroles; Recurrence; Spinal Cord; Th1 Cells	2003
Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP : Journal of the pancreas, 2004, Nov-10, Volume: 5, Issue:6 Topics: Acute Disease; Aged; Atorvastatin; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pancreatitis; Pyrimidines; Pyrroles; Recurrence; Rosuvastatin Calcium; Sulfonamides	2004
A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. The European journal of health economics : HEPAC : health economics in prevention and care, 2004, Volume: 5, Issue:3 Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Coronary Artery Bypass; Cost Savings; Cost-Benefit Analysis; Diagnosis-Related Groups; Double-Blind Method; Economics, Pharmaceutical; Heptanoic Acids; Humans; Multicenter Studies as Topic; Myocardial Infarction; Placebos; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Spain; Syndrome; Time Factors; Treatment Outcome	2004
Gabapentin-induced myopathy in 2 patients on short daily hemodialysis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 45, Issue:6 Topics: Adult; Amines; Anticonvulsants; Atorvastatin; Calcium Channels; Comorbidity; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Neuromuscular Diseases; Peritoneal Dialysis; Physical Exertion; Postoperative Complications; Pyrroles; Recurrence; Renal Dialysis; Restless Legs Syndrome	2005
C-reactive protein levels and outcomes after statin therapy. Current atherosclerosis reports, 2006, Volume: 8, Issue:1 Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Multicenter Studies as Topic; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors	2006
[After TIA and stroke: a statin for secondary prevention?]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Anticholesteremic Agents; Atorvastatin; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Placebos; Pyrroles; Recurrence; Stroke; Time Factors	2006
[Musculoskeletal adverse effects of levofloxacin]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:4 Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Atorvastatin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Doxycycline; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Levofloxacin; Middle Aged; Ofloxacin; Postoperative Complications; Prosthesis-Related Infections; Pyrroles; Recurrence; Reoperation; Rifampin; Thyroiditis, Autoimmune; Thyroxine; Trimethoprim, Sulfamethoxazole Drug Combination	2006
Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. Heart (British Cardiac Society), 2007, Volume: 93, Issue:8 Topics: Aged; Atorvastatin; Chi-Square Distribution; Coronary Disease; Drug Administration Schedule; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lovastatin; Male; Pravastatin; Proportional Hazards Models; Pyrroles; Recurrence; Retrospective Studies; Simvastatin; Treatment Outcome	2007
[Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure]. Nederlands tijdschrift voor geneeskunde, 2007, Mar-03, Volume: 151, Issue:9 Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol; Heptanoic Acids; Humans; Ischemic Attack, Transient; Pyrroles; Recurrence; Risk Factors; Stroke	2007
High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. Journal of the cardiometabolic syndrome, 2008,Winter, Volume: 3, Issue:1 Topics: Adult; Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Stroke	2008
Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction. The American journal of cardiology, 1998, Mar-01, Volume: 81, Issue:5 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Heptanoic Acids; Humans; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Research Design; Treatment Outcome	1998
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. The New England journal of medicine, 1999, Dec-09, Volume: 341, Issue:24 Topics: Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Heptanoic Acids; Humans; Hypercholesterolemia; Myocardial Ischemia; Pyrroles; Recurrence	1999
Effect of statin therapy on restenosis after coronary stent implantation. The American journal of cardiology, 2000, Apr-15, Volume: 85, Issue:8 Topics: Anticholesteremic Agents; Atorvastatin; Case-Control Studies; Coronary Angiography; Coronary Disease; Disease-Free Survival; Fatty Acids, Monounsaturated; Female; Fluvastatin; Follow-Up Studies; Heptanoic Acids; Humans; Hyperplasia; Indoles; Lovastatin; Male; Middle Aged; Pyrroles; Recurrence; Retrospective Studies; Simvastatin; Stents; Time Factors; Tunica Intima	2000
Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting. The American journal of cardiology, 2000, Nov-15, Volume: 86, Issue:10 Topics: Aged; Anticholesteremic Agents; Arrhythmias, Cardiac; Atorvastatin; Cause of Death; Coronary Artery Bypass; Coronary Disease; Female; Heart Failure; Heptanoic Acids; Humans; Hypercholesterolemia; Incidence; Lovastatin; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Preoperative Care; Pyrroles; Recurrence; Retrospective Studies; Risk Factors; Simvastatin; Stroke; Treatment Outcome	2000